The effect of vaginal boswellia gel on vaginal candidiasis

The effect of vaginal boswellia gel on vaginal candidiasis in firoozgar hospital with smear and culture

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200701047977N1

Enrollment

180

Registered

2021-07-04

Start date

2021-08-21

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vaginit candidiasis.

Interventions

Intervention group: Prescribing frankincense vaginal gel containing 2% frankincense. First, glyprol propylene extract: water (20-80) is prepared by fumigation by frankincense. The prepared extract is

Eligibility

Sex/Gender

Female

Age

20 Years to 55 Years

Inclusion criteria

Inclusion criteria: female 20 - 55 years old married itching, burning, pain, dyspareunia diagnose of vaginal candidiasis by physician do not use of antibiotic and corticosteroide in 2weeks ago

Exclusion criteria

Exclusion criteria: use of antibiotic in 2 weeks ago pregnancy breastfeeding backward addiction use of systemic corticosteroid or OCP diabetes anatomic problems in vulve and vagina other sexual infections abnormal vaginal bleeding

Design outcomes

Primary

Measure	Time frame
Comparison of symptoms of pain, burning, itching and vaginal discharge in patients with candidal vaginal infection. Timepoint: 2 days after treatment. Method of measurement: Filling in the clinical symptoms questionnaire of the Iranian Dermatological Association.;Comparison of symptoms of burning in patients with candidal vaginal infection. Timepoint: 2 days after treatment. Method of measurement: Filling in the clinical symptoms questionnaire of the Iranian Dermatological Association.;Comparison of symptoms of itching in patients with candidal vaginal infection. Timepoint: 2 days after treatment. Method of measurement: Filling in the clinical symptoms questionnaire of the Iranian Dermatological Association.;Comparison of symptoms of vaginal discharge in patients with candidal vaginal infection. Timepoint: 2 days after treatment. Method of measurement: Filling in the clinical symptoms questionnaire of the Iranian Dermatological Association.;Comparison of symptoms of dyspareunia in patients with candidal vaginal infection. Timepoint: 2 days after treatment. Method of measurement: Filling in the clinical symptoms questionnaire of the Iranian Dermatological Association.	—

Measure

Time frame

Comparison of symptoms of pain, burning, itching and vaginal discharge in patients with candidal vaginal infection. Timepoint: 2 days after treatment. Method of measurement: Filling in the clinical symptoms questionnaire of the Iranian Dermatological Association.;Comparison of symptoms of burning in patients with candidal vaginal infection. Timepoint: 2 days after treatment. Method of measurement: Filling in the clinical symptoms questionnaire of the Iranian Dermatological Association.;Comparison of symptoms of itching in patients with candidal vaginal infection. Timepoint: 2 days after treatment. Method of measurement: Filling in the clinical symptoms questionnaire of the Iranian Dermatological Association.;Comparison of symptoms of vaginal discharge in patients with candidal vaginal infection. Timepoint: 2 days after treatment. Method of measurement: Filling in the clinical symptoms questionnaire of the Iranian Dermatological Association.;Comparison of symptoms of dyspareunia in patients with candidal vaginal infection. Timepoint: 2 days after treatment. Method of measurement: Filling in the clinical symptoms questionnaire of the Iranian Dermatological Association.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojgan Tansaz

Shahid Beheshti University of Medical Sciences

dr.fheydarian@yahoo.com+98 21 2254 0233

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026